PortfoliosLab logoPortfoliosLab logo
KEMX vs. NVOH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

KEMX vs. NVOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

KEMX vs. NVOH - Yearly Performance Comparison


Returns By Period

In the year-to-date period, KEMX achieves a 9.09% return, which is significantly higher than NVOH's -24.75% return.


KEMX

1D
-1.38%
1M
-4.33%
YTD
9.09%
6M
19.23%
1Y
48.69%
3Y*
20.08%
5Y*
9.00%
10Y*

NVOH

1D
-1.00%
1M
0.42%
YTD
-24.75%
6M
-34.28%
1Y
-46.24%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


KEMX vs. NVOH - Expense Ratio Comparison

KEMX has a 0.25% expense ratio, which is higher than NVOH's 0.19% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Return for Risk

KEMX vs. NVOH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEMX
KEMX Risk / Return Rank: 9191
Overall Rank
KEMX Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
KEMX Sortino Ratio Rank: 9393
Sortino Ratio Rank
KEMX Omega Ratio Rank: 9292
Omega Ratio Rank
KEMX Calmar Ratio Rank: 8787
Calmar Ratio Rank
KEMX Martin Ratio Rank: 8989
Martin Ratio Rank

NVOH
NVOH Risk / Return Rank: 11
Overall Rank
NVOH Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NVOH Sortino Ratio Rank: 11
Sortino Ratio Rank
NVOH Omega Ratio Rank: 11
Omega Ratio Rank
NVOH Calmar Ratio Rank: 11
Calmar Ratio Rank
NVOH Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KEMX vs. NVOH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KEMXNVOHDifference

Sharpe ratio

Return per unit of total volatility

2.28

-0.88

+3.16

Sortino ratio

Return per unit of downside risk

2.92

-1.14

+4.06

Omega ratio

Gain probability vs. loss probability

1.42

0.84

+0.58

Calmar ratio

Return relative to maximum drawdown

3.21

-0.89

+4.10

Martin ratio

Return relative to average drawdown

12.94

-1.51

+14.45

KEMX vs. NVOH - Sharpe Ratio Comparison

The current KEMX Sharpe Ratio is 2.28, which is higher than the NVOH Sharpe Ratio of -0.88. The chart below compares the historical Sharpe Ratios of KEMX and NVOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


KEMXNVOHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.28

-0.88

+3.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.50

-0.98

+1.48

Correlation

The correlation between KEMX and NVOH is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

KEMX vs. NVOH - Dividend Comparison

KEMX's dividend yield for the trailing twelve months is around 3.01%, less than NVOH's 4.56% yield.


TTM2025202420232022202120202019
KEMX
KraneShares MSCI Emerging Markets ex China Index ETF
3.01%3.28%3.39%2.00%4.10%4.79%1.69%2.77%
NVOH
Novo Nordisk A/S (B Shares) ADRhedged ETF
4.56%2.38%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

KEMX vs. NVOH - Drawdown Comparison

The maximum KEMX drawdown since its inception was -38.80%, smaller than the maximum NVOH drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for KEMX and NVOH.


Loading graphics...

Drawdown Indicators


KEMXNVOHDifference

Max Drawdown

Largest peak-to-trough decline

-38.80%

-61.60%

+22.80%

Max Drawdown (1Y)

Largest decline over 1 year

-15.36%

-53.00%

+37.64%

Max Drawdown (5Y)

Largest decline over 5 years

-30.85%

Current Drawdown

Current decline from peak

-11.89%

-60.40%

+48.51%

Average Drawdown

Average peak-to-trough decline

-9.02%

-36.02%

+27.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.81%

31.21%

-27.40%

Volatility

KEMX vs. NVOH - Volatility Comparison

KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a higher volatility of 11.42% compared to Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) at 8.19%. This indicates that KEMX's price experiences larger fluctuations and is considered to be riskier than NVOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


KEMXNVOHDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.42%

8.19%

+3.23%

Volatility (6M)

Calculated over the trailing 6-month period

17.04%

37.53%

-20.49%

Volatility (1Y)

Calculated over the trailing 1-year period

21.46%

52.51%

-31.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.56%

51.04%

-33.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.61%

51.04%

-30.43%